Literature DB >> 2556982

Latent HSV-1 infection in mice immunized with a zwitterionic detergent-extracted HSV-1 antigen preparation.

A al-Ghamdi1, R Jennings, H Bentley, C W Potter.   

Abstract

A HSV-1 antigen preparation obtained by zwitterionic detergent-extraction of HSV-1 infected Vero cells was investigated for its ability to protect mice against establishment of latent infection in the trigeminal ganglion following HSV-1 challenge by ear scarification. The antigen preparation was shown to induce antibody production and correlation between pre-challenge antibody level and establishment of latency was found. Although immunization did not reduce the overall incidence of ear erythema following challenge the duration of erythema was significantly decreased. Latency in the trigeminal ganglion was also significantly reduced in vaccinated mice and in addition, a correlation was found between the duration of erythema and latency, there being significantly more latent infections in mice with erythema of three or more days duration, than in those with erythema lasting less than three days.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556982     DOI: 10.1007/BF01313739

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  29 in total

Review 1.  Herpes simplex virus latency.

Authors:  T J Hill; D M Altmann; W A Blyth; D A Harbour; A Whitby
Journal:  Clin Dermatol       Date:  1984 Apr-Jun       Impact factor: 3.541

2.  Typing of herpes simplex virus by an enzyme-linked immunosorbent assay with monoclonal antibodies.

Authors:  E Nilheden; S Jeansson; A Vahlne
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

3.  Efficacy of a nucleic acid free herpetic subunit vaccine.

Authors:  R Cappel; F de Cuyper; F Rickaert
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

4.  Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice.

Authors:  K J Cremer; M Mackett; C Wohlenberg; A L Notkins; B Moss
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

5.  Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine.

Authors:  E N Kitces; P S Morahan; J G Tew; B K Murray
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

6.  Antibody responses and protection in mice immunized with herpes simplex virus type 1 antigen immune-stimulating complex preparations.

Authors:  M Ertürk; R Jennings; D Hockley; C W Potter
Journal:  J Gen Virol       Date:  1989-08       Impact factor: 3.891

7.  Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.

Authors:  J F Rooney; C Wohlenberg; K J Cremer; B Moss; A L Notkins
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

8.  Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs.

Authors:  P W Berman; P E Vogt; T Gregory; L A Lasky; E R Kern
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

9.  Recurrent herpes simplex in the mouse: inflammation in the skin and activation of virus in the ganglia following peripheral stimulation.

Authors:  D A Harbour; T J Hill; W A Blyth
Journal:  J Gen Virol       Date:  1983-07       Impact factor: 3.891

10.  Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice.

Authors:  R J Klein; E Buimovici-Klein; H Moser; R Moucha; J Hilfenhaus
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

View more
  3 in total

1.  Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine.

Authors:  M Erturk; T J Hill; C Shimeld; R Jennings
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Immunogenicity of influenza and HSV-1 mixed antigen ISCOMs in mice.

Authors:  H O Ghazi; M Erturk; L M Stannard; M Faulkner; C W Potter; R Jennings
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 3.  Developments in herpes simplex virus vaccines: old problems and new challenges.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.